Driving Adenovirus Type12-Transformed BALB/cMouseCellsTo Express HighLevels ofClassIMajorHistocompatibili ty ComplexProteins Enhances, Rather Than Abrogates, TheirTumorigenicity
暂无分享,去创建一个
[1] T. Wesslén. SV40-tumorigenesis in mouse. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.
[2] G. Blair,et al. Nuclear proteins binding to an enhancer element of the major histocompatibility class I promoter: differences between highly oncogenic and nononcogenic adenovirus-transformed rat cells. , 1989, Virology.
[3] P. Leder,et al. Murine interleukin-4 displays potent anti-tumor activity in vivo , 1989, Cell.
[4] Eric O Long,et al. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. , 1988, Journal of immunology.
[5] T. Shenk,et al. Adenovirus tumor-specific transplantation antigen is a function of the E1A early region , 1986, The Journal of experimental medicine.
[6] J. Seidman,et al. Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens , 1982, Nature.
[7] R. Schwartz. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. , 1985, Annual review of immunology.
[8] A. Eb,et al. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells , 1983, Nature.
[9] K. Lafferty,et al. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.